The Effect of Enzastaurin on CYP2C9: Enzastaurin - S-Warfarin Drug Interaction Study in Patients With Cancer.
Phase of Trial: Phase I
Latest Information Update: 17 Dec 2012
At a glance
- Drugs Enzastaurin; Warfarin
- Indications Lymphoma; Solid tumours
- Focus Pharmacokinetics
- 01 Dec 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 10 Aug 2011 Actual initiation date (Aug 2011) added as reported by ClinicalTrials.gov.